Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
A review of current developments in RNA modifications in lung cancer
Shujun Zhang1, Yafeng Liu1, Kaijie Liu1
1Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471000, Henan, China.
Abstract:
Lung cancer has the highest incidence and mortality rates worldwide and is the primary cause of cancer-related death. Despite the rapid development of diagnostic methods and targeted drugs in recent years, many lung cancer patients do not benefit from effective therapies. The emergence of drug resistance has led to a reduction in the therapeutic effectiveness of targeted drugs, highlighting a crucial need to explore novel therapeutic targets. Many studies have found that epigenetic plays an important role in the occurrence of lung cancer. This review describes the biological function of epigenetic RNA modifications, such as m6A, m5C, m7G, and m1A, and recent advancements in their role in the development, progression, and prognosis of lung cancer. This review aims to provide new guidance for the treatment of lung cancer.
Insights
Epigenetic RNA modifications, including m6A, m5C, m7G, and m1A, are crucial in lung cancer development and drug resistance. Understanding these mechanisms offers new therapeutic targets for lung cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Lung cancer exhibits high global incidence and mortality, with limited therapeutic benefits for many patients.
- Acquired drug resistance diminishes the effectiveness of current targeted therapies, necessitating novel therapeutic strategies.
- Epigenetic alterations are increasingly recognized as significant contributors to lung cancer pathogenesis.
Purpose of the Study:
- To review the biological functions of key epigenetic RNA modifications.
- To summarize recent advancements in understanding their roles in lung cancer development, progression, and prognosis.
- To provide insights for identifying new therapeutic targets in lung cancer.
Main Methods:
- Literature review of epigenetic RNA modifications in lung cancer.
- Analysis of the roles of m6A, m5C, m7G, and m1A in cancer biology.
- Synthesis of current research on their clinical implications.
Main Results:
- Epigenetic RNA modifications significantly influence lung cancer initiation and advancement.
- These modifications are implicated in the development of resistance to targeted therapies.
- Specific modifications like m6A, m5C, m7G, and m1A show potential as prognostic biomarkers.
Conclusions:
- Epigenetic RNA modifications represent a critical area for understanding lung cancer.
- Targeting these modifications may overcome drug resistance and improve patient outcomes.
- Further research into these mechanisms can guide the development of novel lung cancer treatments.
Related Concept Videos
RNA Editing
RNA Stability
MicroRNAs
lncRNA - Long Non-coding RNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps

